Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MTF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
BACH2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
LOC101928054 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
SNIP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PHTF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
METTL14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MDGA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RNF38 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SAMD4A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZCCHC3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LZTS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HTR7P1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CENPH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAPK1IP1L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ERRFI1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SAT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ESYT2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on